/ /

Greg Hill
Understanding the link between MGD and OSD
Meibomian gland dysfunction (MGD) may be misdiagnosed. While MGD is one of the most common chronic ocular conditions, diagnosing MGD isn’t as simple as it seems.
How ODs can ease the pain of patient referrals
Not all situations can be handled within one office, so sometimes it is necessary to refer patients elsewhere. Despite the logic behind them, referrals often come bundled with liabilities that can give any OD a headache.
Stem cells offering faint cure possibility for glaucoma
Stem cell technology may soon enter the mainstream as a treatment for ocular disease, says Leo Semes, OD, FAAO, at this year’s annual SECO 2017 conference.
New research, interest advancing retinal care
Treatment of posterior segment disease is in the midst of a paradigm shift, says a panel of experts at this year's annual SECO 2017 conference in Atlanta.
Addressing scleral lens clinical concerns
While scleral lenses offer more stability than traditional lenses, there are still many controversies about their use that may give practitioners pause
Gladwell: Health care is a mystery wrapped in a puzzle
The current state of health care in the U.S. is a blend of pathologies and policies
How to reduce vision impairment, promote eye health
The American healthcare system is failing eye care
ECPs don’t treat glaucoma aggressively enough
Glaucoma isn’t being treated aggressively enough, and eyecare practitioners are being too cautious when it comes to treating and diagnosing the disease—often at the patient’s expense.


View Results